[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344444-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344444-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-ccr1-as-a-decisive-factor-for-immune-response-activation-versus-suppression-phenotypes-in-gastric-cancer","The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer","","Chemokine receptor 1 (CCR1) regulates immune cell migration, yet its function within the gastric cancer immune microenvironment remains insufficiently defined. This study combines transcriptomic profiling and clinical correlation analyses with functional in vivo validation using CCR1-knockout mice and macrophage depletion, supported by protein and gene expression assays. Results show CCR1 is mainly expressed on macrophages and promotes T-cell recruitment via NF-κB/MAPK-driven CXCL9/CXCL10 expression, shaping activation versus suppression phenotypes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-ccr1-as-a-decisive-factor-for-immune-response-activation-versus-suppression-phenotypes-in-gastric-cancer/344444/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-ccr1-as-a-decisive-factor-for-immune-response-activation-versus-suppression-phenotypes-in-gastric-cancer/344444.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central question of the study about CCR1 in gastric cancer?","Question",{"text":63,"@type":64},"Whether CCR1 promotes or suppresses gastric cancer progression within the tumor immune microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cell type shows predominant CCR1 expression according to the transcriptomic analyses?",{"text":68,"@type":64},"CCR1 is predominantly expressed on macrophages.",{"name":70,"@type":61,"acceptedAnswer":71},"How does CCR1 mechanistically influence T-cell recruitment in the tumor microenvironment?",{"text":72,"@type":64},"CCR1 activates NF-κB and MAPK pathways in macrophages, upregulating CXCL9 and CXCL10 to enhance T-cell recruitment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344444,1790093919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Neoplasia 73 (2026) 101277  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer\u003Cbr>Keran Sun a,b,1, Jingyuan Ning a,b,1, Keqi Jiac, Xiaoqing Fan a,b, Hongru Lia,b,\u003Cbr>Cuiqing Ma a,b,*, Lin Wei a,b,* \u003Cbr>a Department of Immunology, School of Basic Medical Sciences, Hebei Medical University, Shijiazhuang, Hebei, China b Key Laboratory of Immune Mechanism and Intervention for Major Diseases of Hebei, Shijiazhuang, Hebei, China c Department of Pathology, Shijiazhuang People's Hospital, Shijiazhuang, China |  |  | |\n| --- | --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords: CCR1\u003Cbr>Macrophage Gastric cancer\u003Cbr>Immune microenvironment T cell infiltration |  | Background: Chemokine receptor 1 (CCR1), a regulator of immune cell migration, has been implicated in various cancers but remains poorly characterized in gastric cancer's immune microenvironment. This study aimed to investigate whether CCR1 promotes or suppresses tumor progression in gastric cancer.\u003Cbr>Methods: Utilize transcriptomic analysis to investigate the role of CCR1 in gastric cancer, and employed clinical data to examine the correlation between CCR1 expression and patient survival as well as pathological features. In vivo models with CCR1-knockout mice and macrophage depletion experiments validated functional roles, while Western blotting and qRT-PCR explored The pathways and signaling.\u003Cbr>Results: Following patient stratification based on optimal cut-off values, Kaplan-Meier survival analysis demonstrated that patients with high CCR1 expression had longer survival times. Single-cell and spatial transcriptomics analyses revealed that CCR1 is predominantly expressed on macrophages. Immunofluorescence assays showed greater co-localization of CCR1 and CD68 in gastric cancer tissues compared to adjacent normal tissues, confirming CCR1 expression in macrophages. In vivo experiments demonstrated that CCR1 deficiency increased tumor growth by reducing T cell infiltration, an effect that was abrogated by macrophage depletion. Mechanistically, CCR1 activates the NF-κB and MAPK pathways in macrophages to upregulate CXCL9 and CXCL10, thereby promoting T cell recruitment to the tumor microenvironment.\u003Cbr>Conclusions: CCR1 modulates T cell distribution via CXCL9/CXCL10, suggesting potential therapeutic directions. |  |\n\nIntroduction  \nAs the fifth most common malignancy globally, gastric cancer remains a significant threat to international health; in 2022, it was reported to have 968,000 new occurrences and 660,000 fatalities [1]. Even though the worldwide prevalence of Helicobacter pylori infection has declined from 58.2% to 43.1% over the course of the past four decades [2–4], this pathogen remains the predominant modifiable risk factor, with eradication strategies demonstrating a 50% reduction in gastric cancer risk among high-risk individuals [5]. The therapeutic landscape has been revolutionized by immune checkpoint inhibitors, with nivolumab plus chemotherapy receiving FDA approval in April 2021 following the landmark CheckMate-649 trial, which demonstrated  \nimproved overall survival in patients with PD-L1 combined positive score (CPS) ≥5 [6]. This trial demonstrated that nivolumab plus chemotherapy significantly improved overall survival (OS) compared to chemotherapy alone in patients with PD-L1 CPS≥5, with additional benefits observed in the PD-L1 CPS≥1 population and all randomized patients [6]. However, subsequent subgroup analysis revealed that patients with PD-L1 CPS 1-4 did not achieve significant OS benefit [7], highlighting the importance of identifying additional biomarkers beyond PD-L1. Subsequently, pembrolizumab gained approval for first-line treatment based on KE","cbCaiogweLptXvkb","https://ap.wps.com/l/cbCaiogweLptXvkb","pdf",17353471,13,"English","# Introduction\n# Methods\n## Transcriptomic and clinical analyses\n## In vivo functional experiments\n# Results\n## CCR1 expression pattern\n## Effects on tumor growth and T-cell infiltration\n## Mechanistic pathway activation\n# Conclusions","[{\"question\":\"What is the central question of the study about CCR1 in gastric cancer?\",\"answer\":\"Whether CCR1 promotes or suppresses gastric cancer progression within the tumor immune microenvironment.\"},{\"question\":\"Which cell type shows predominant CCR1 expression according to the transcriptomic analyses?\",\"answer\":\"CCR1 is predominantly expressed on macrophages.\"},{\"question\":\"How does CCR1 mechanistically influence T-cell recruitment in the tumor microenvironment?\",\"answer\":\"CCR1 activates NF-κB and MAPK pathways in macrophages, upregulating CXCL9 and CXCL10 to enhance T-cell recruitment.\"}]","The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer | PDF",1790053768,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c5b8e3a0461f887972b5da416014273.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dda1f9970e3bd61e9eba9fce54246036.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3547f9a75d722428749b4a356f0c872.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/317158424740b18db7066cfb0bb10e9d.webp",980,1306]